BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35041454)

  • 1. Impact of Frailty and Prefrailty on Outcomes of Transcatheter or Surgical Aortic Valve Replacement.
    Arnold SV; Zhao Y; Leon MB; Sathananthan J; Alu M; Thourani VH; Smith CR; Mack MJ; Cohen DJ
    Circ Cardiovasc Interv; 2022 Jan; 15(1):e011375. PubMed ID: 35041454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
    Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis.
    Arnold SV; Chinnakondepalli KM; Magnuson EA; Reardon MJ; Deeb GM; Gleason T; Yakubov SJ; Cohen DJ;
    JAMA Cardiol; 2021 Jan; 6(1):97-101. PubMed ID: 32997095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement.
    Abbas AE; Ternacle J; Pibarot P; Xu K; Alu M; Rogers E; Hahn RT; Leon M; Thourani VH
    Circ Cardiovasc Imaging; 2021 Aug; 14(8):e012364. PubMed ID: 34387097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Costs Associated With Transcatheter Versus Surgical Aortic Valve Replacement in Medicare Beneficiaries.
    Baron SJ; Ryan MP; Moore KA; Clancy SJ; Gunnarsson CL
    Circ Cardiovasc Interv; 2022 Mar; 15(3):e011295. PubMed ID: 35193382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Okoh AK; Chauhan D; Kang N; Haik N; Merlo A; Cohen M; Haik B; Chen C; Russo MJ
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1000-1006. PubMed ID: 28463403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement.
    Strom JB; Xu J; Orkaby AR; Shen C; Song Y; Charest BR; Kim DH; Cohen DJ; Kramer DB; Spertus JA; Gerszten RE; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e008566. PubMed ID: 34779656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.
    Galper BZ; Chinnakondepalli KM; Wang K; Magnuson EA; Lu M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Williams M; Webb J; Smith CR; Mack MJ; Leon MB; Cohen DJ;
    Circulation; 2023 May; 147(21):1594-1605. PubMed ID: 37154049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Kapadia SR; Huded CP; Kodali SK; Svensson LG; Tuzcu EM; Baron SJ; Cohen DJ; Miller DC; Thourani VH; Herrmann HC; Mack MJ; Szerlip M; Makkar RR; Webb JG; Smith CR; Rajeswaran J; Blackstone EH; Leon MB;
    J Am Coll Cardiol; 2018 Nov; 72(20):2415-2426. PubMed ID: 30442284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.
    Pibarot P; Weissman NJ; Stewart WJ; Hahn RT; Lindman BR; McAndrew T; Kodali SK; Mack MJ; Thourani VH; Miller DC; Svensson LG; Herrmann HC; Smith CR; Rodés-Cabau J; Webb J; Lim S; Xu K; Hueter I; Douglas PS; Leon MB
    J Am Coll Cardiol; 2014 Sep; 64(13):1323-34. PubMed ID: 25257633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Prefrailty and Frailty in Women Undergoing TAVR: Insights From the WIN-TAVI Registry.
    Petrovic M; Spirito A; Sartori S; Vogel B; Tchetche D; Petronio AS; Mehilli J; Lefevre T; Presbitero P; Capranzano P; Pileggi B; Iadanza A; Sardella G; van Mieghem NM; Meliga E; Feng Y; Dumonteil N; Cohen R; Fraccaro C; Trabattoni D; Mikhail G; Ferrer-Gracia MC; Naber C; Sharma SK; Watanabe Y; Morice MC; Dangas GD; Chieffo A; Mehran R
    Can J Cardiol; 2024 Mar; 40(3):457-467. PubMed ID: 37923124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.